Trinity Biotech reported $11.03M in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Bayer BAYN:GR 5.89B 414M
Bio Rad Laboratories BIO:US $ 441.56M 38.86M
Edap Tms EDAP:US $ 3.62M 0.59M
Johnson & Johnson JNJ:US $ 16088M 343M
Mesa Laboratories MLAB:US $ 23.14M 0.93M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Siemens SIE:GR 6.31B 435M
Sientra SIEN:US 10.59M 675K
Surmodics SRDX:US $ 19.81M 1.04M
Thermo Fisher Scientific TMO:US $ 4797M 273M
Tosoh 4042:JP 65.62B 5.28B
Trinity Biotech TRIB:US $ 11.03M 0.11M
Veracyte VCYT:US $ 38.73M 1.09M